We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JAX
3576
DELISTED
J. Alexander's Holdings, Inc.
JAX
$25K ﹤0.01%
5,098
+1,073
+27% +$4.88K
GEN
3577
DELISTED
Genesis Healthcare, Inc.
GEN
$25K ﹤0.01%
36,094
+26,344
+270% +$21.2K
ASFI
3578
DELISTED
Asta Funding Inc
ASFI
$25K ﹤0.01%
1,956
+1,918
+5,047% +$21.5K
ACWV icon
3579
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
$24K ﹤0.01%
+278
New +$24.1K
BPRN icon
3580
Princeton Bancorp
BPRN
$287M
$24K ﹤0.01%
+1,173
New +$23.7K
CBAN icon
3581
Colony Bankcorp
CBAN
$467M
$24K ﹤0.01%
+2,040
New +$23.7K
EOS
3582
Eaton Vance Enhance Equity Income Fund II
EOS
$1.18B
$24K ﹤0.01%
+1,382
New +$22.6K
EPU icon
3583
iShares MSCI Peru and Global Exposure ETF
EPU
$554M
$24K ﹤0.01%
836
+431
+106% +$11.4K
EVI icon
3584
EVI Industries
EVI
$184M
$24K ﹤0.01%
1,104
+613
+125% +$12.1K
FCEL icon
3585
FuelCell Energy
FCEL
$1.58B
$24K ﹤0.01%
353
-47
-12% -$2.9K
IRMD icon
3586
iRadimed
IRMD
$1.15B
$24K ﹤0.01%
1,053
+934
+785% +$20.1K
MKC.V icon
3587
McCormick & Company Voting
MKC.V
$14.3B
$24K ﹤0.01%
266
-208
-44% -$17.2K
NGNE icon
3588
Neurogene
NGNE
$634M
$24K ﹤0.01%
74
-27
-27% -$7.04K
NWS icon
3589
News Corp Class B
NWS
$17.7B
$24K ﹤0.01%
2,015
-4,171
-67% -$45.2K
TCI icon
3590
Transcontinental Realty Investors
TCI
$321M
$24K ﹤0.01%
793
-1,191
-60% -$27.5K
UNTY icon
3591
Unity Bancorp
UNTY
$600M
$24K ﹤0.01%
+1,700
New +$23.2K
USFD icon
3592
US Foods
USFD
$24.2B
$24K ﹤0.01%
1,200
-11,574
-91% -$221K
VEON icon
3593
VEON
VEON
$3.94B
$24K ﹤0.01%
+534
New +$21.5K
ZNTL icon
3594
Zentalis Pharmaceuticals
ZNTL
$292M
$24K ﹤0.01%
+510
New +$19.6K
SHPW
3595
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$24K ﹤0.01%
+304
New +$23.8K
BXG
3596
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
$24K ﹤0.01%
+4,409
New +$21K
RLH
3597
DELISTED
Red Lions Hotel Corporation
RLH
$24K ﹤0.01%
10,180
+9,327
+1,093% +$16.7K
PEI
3598
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$24K ﹤0.01%
+1,176
New +$21.2K
ALTO icon
3599
Alto Ingredients
ALTO
$323M
$23K ﹤0.01%
+31,891
New +$16.1K
BFIN
3600
DELISTED
BankFinancial
BFIN
$23K ﹤0.01%
+2,757
New +$22.1K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.